Formulary considerations for treating psychiatric disorders

Schizophrenia

E. Risby, D. Donnigan, Charles Nemeroff

Research output: Contribution to journalArticle

Abstract

Schizophrenia is a severe psychiatric disorder that causes major public health problems. Pharmacotherapy for the condition is divided into two groups: conventional (neuroleptic) and atypical antipsychotics. Conventional agents are effective against positive symptoms of schizophrenia and have a low acquisition cost; however, the risk of significant adverse effects-extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome-limit their use. Atypical antipsychotics, however, appear to provide greater efficacy, including effectiveness against both positive and negative symptoms, than the neuroleptics and, in general, have a more favorable side effect profile. This article reviews both the conventional and atypical treatments available for the treatment of schizophrenia.

Original languageEnglish
Pages (from-to)142-155
Number of pages14
JournalFormulary
Volume32
Issue number2
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Formularies
Antipsychotic Agents
Psychiatry
Schizophrenia
Neuroleptic Malignant Syndrome
Public Health
Costs and Cost Analysis
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Formulary considerations for treating psychiatric disorders : Schizophrenia. / Risby, E.; Donnigan, D.; Nemeroff, Charles.

In: Formulary, Vol. 32, No. 2, 01.01.1997, p. 142-155.

Research output: Contribution to journalArticle

Risby, E. ; Donnigan, D. ; Nemeroff, Charles. / Formulary considerations for treating psychiatric disorders : Schizophrenia. In: Formulary. 1997 ; Vol. 32, No. 2. pp. 142-155.
@article{73d19ad0ffb84c648727984c55c8b089,
title = "Formulary considerations for treating psychiatric disorders: Schizophrenia",
abstract = "Schizophrenia is a severe psychiatric disorder that causes major public health problems. Pharmacotherapy for the condition is divided into two groups: conventional (neuroleptic) and atypical antipsychotics. Conventional agents are effective against positive symptoms of schizophrenia and have a low acquisition cost; however, the risk of significant adverse effects-extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome-limit their use. Atypical antipsychotics, however, appear to provide greater efficacy, including effectiveness against both positive and negative symptoms, than the neuroleptics and, in general, have a more favorable side effect profile. This article reviews both the conventional and atypical treatments available for the treatment of schizophrenia.",
author = "E. Risby and D. Donnigan and Charles Nemeroff",
year = "1997",
month = "1",
day = "1",
language = "English",
volume = "32",
pages = "142--155",
journal = "Formulary",
issn = "0098-6909",
publisher = "Advanstar Communications",
number = "2",

}

TY - JOUR

T1 - Formulary considerations for treating psychiatric disorders

T2 - Schizophrenia

AU - Risby, E.

AU - Donnigan, D.

AU - Nemeroff, Charles

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Schizophrenia is a severe psychiatric disorder that causes major public health problems. Pharmacotherapy for the condition is divided into two groups: conventional (neuroleptic) and atypical antipsychotics. Conventional agents are effective against positive symptoms of schizophrenia and have a low acquisition cost; however, the risk of significant adverse effects-extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome-limit their use. Atypical antipsychotics, however, appear to provide greater efficacy, including effectiveness against both positive and negative symptoms, than the neuroleptics and, in general, have a more favorable side effect profile. This article reviews both the conventional and atypical treatments available for the treatment of schizophrenia.

AB - Schizophrenia is a severe psychiatric disorder that causes major public health problems. Pharmacotherapy for the condition is divided into two groups: conventional (neuroleptic) and atypical antipsychotics. Conventional agents are effective against positive symptoms of schizophrenia and have a low acquisition cost; however, the risk of significant adverse effects-extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome-limit their use. Atypical antipsychotics, however, appear to provide greater efficacy, including effectiveness against both positive and negative symptoms, than the neuroleptics and, in general, have a more favorable side effect profile. This article reviews both the conventional and atypical treatments available for the treatment of schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0031017440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031017440&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 142

EP - 155

JO - Formulary

JF - Formulary

SN - 0098-6909

IS - 2

ER -